Drugplain

Lithium 8 meq/5mL

Lithium · SOLUTION · PAI Holdings, LLC dba PAI Pharma

7 Recalls on Record
Plain English

Lithium is a solution containing lithium at 8 meq/5mL, taken oral. Manufactured by PAI Holdings, LLC dba PAI Pharma.

Key Facts

Brand Name
Lithium
Generic Name
Lithium
NDC Code (Product)
0121-4027
Manufacturer
PAI Holdings, LLC dba PAI Pharma
Strength
8 meq/5mL
Dosage Form
SOLUTION
Route
ORAL
Marketing Status
Application #
ANDA070755
Marketing Start
04/14/2026

Recall History

7 Recalls on Record
Class II03/15/2021

Cardinal Health Inc.

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

TerminatedVoluntary: Firm initiated
Class II01/26/2022

CARDINAL HEALTHCARE

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

TerminatedVoluntary: Firm initiated
Class II11/17/2016

Tri-Coast Pharmacy

Lack of Assurance of Sterility

OngoingVoluntary: Firm initiated
Class II07/02/2013

Aidapak Services, LLC

Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 450 mg may be potentially mislabled as one of the following drugs: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD21790_19, EXP: 5/1/2014; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 MILLION CFU, NDC 43292050022, Pedigree: AD46257_28, EXP: 5/15/2014; HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W002729, EXP: 6

TerminatedVoluntary: Firm initiated
Class II05/21/2012

Franck's Lab Inc., d.b.a. Franck's Compounding Lab

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

TerminatedVoluntary: Firm initiated
Class II07/02/2013

Aidapak Services, LLC

Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg) may be potentially mislabled as one of the following drugs: CYCLOBENZAPRINE HCL, Tablet, 5 mg, NDC 00591325601, Pedigree: AD73525_7, EXP: 5/30/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD21846_11, EXP: 5/1/2014.

TerminatedVoluntary: Firm initiated
Class II07/02/2013

Aidapak Services, LLC

Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 300 mg may be potentially mislabled as the following drug: VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg, NDC 40985022251, Pedigree: AD39588_10, EXP: 5/13/2014.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

toxicity to various agents3,374 reports
drug ineffective3,301 reports
tremor2,534 reports
drug interaction2,516 reports
nausea2,143 reports
off label use2,113 reports
weight increased1,891 reports
fatigue1,730 reports
vomiting1,681 reports
depression1,679 reports

Frequently Asked Questions

What is Lithium used for?

Lithium contains Lithium. It is a solution taken oral. Consult your doctor for specific uses.

Is Lithium a controlled substance?

Lithium is not classified as a controlled substance by the DEA.

What is the generic name for Lithium?

The generic name for Lithium is Lithium. There are 12 other brand versions of Lithium.

What is the NDC code for Lithium 8 meq/5mL?

The NDC (National Drug Code) for Lithium 8 meq/5mL is 0121-4027, listed by PAI Holdings, LLC dba PAI Pharma.